Summary | UOK 268 Cell Line for Hereditary Leiomyomatosis and Renal Cell Carcinoma

Crowdsourcing scientists around the world with orphan and dormant intellectual property (IP).

Join Us Sign In

This is the pilot version of Therapoid. Register or Sign in as a pilot user to collaborate.

Provided by: National Institutes of Health (NIH)
Tags: UOK 268 Leiomyomatosis Kidney Cancer Renal Cell Carcinoma Cell Line

Short Description:

This technology uses the UOK 262 immortalized cell line as research tool to study aggressive hereditary leiomyomatosis and renal cell carcinoma (HLRCC) associated with recurring kidney cancer.

Projects based on this Technology

Start New Project